Disapproval Is Not a Ban. Here Is the Difference and Why It Matters
We handle peptide ad disapprovals every week. A disapproval means Facebook rejected a specific ad but your account is still active. A ban means your entire ad account, or worse your Business Manager, is suspended. The distinction matters because disapprovals have a clear fix path, while bans require a full appeal process that can take weeks.
Most advertisers panic when they see a disapproval and start deleting ads or creating new accounts. That makes things worse. A disapproval is Facebook telling you exactly what to fix. If you read the notice carefully and address the specific violation, you can get the ad approved within 24 to 48 hours.
The Exact Meta Policies That Trigger Peptide Disapprovals
Facebook's Advertising Policies divide restricted content into categories. Peptides fall under two overlapping categories: Restricted Substances and Healthcare and Medicines. The restricted substances policy prohibits ads that promote the sale or use of drugs and drug-related content. The healthcare policy restricts ads for prescription drugs, online pharmacies, and health claims without substantiation.
Policy trigger one: Prescription drug promotion. If your ad mentions a peptide by name and the system classifies it as a prescription drug, the ad is disapproved under the restricted substances policy. The fix is removing all drug names from ad copy and focusing on the consultation or compounding service.
Policy trigger two: Personal attributes. Ads that imply knowledge of a user's personal characteristics, like 'Are you struggling with weight?' get disapproved under Meta's personal attributes policy. The fix is switching to educational language that does not address the user directly about their body or health.
Policy trigger three: Before-and-after imagery. Any image that suggests a physical transformation triggers disapproval under the personal health policy. This includes weight loss photos, muscle gain comparisons, and anti-aging visuals. The fix is using product images, clinic photos, or educational graphics.
Policy trigger four: Non-functional landing page. Meta's crawler checks whether your landing page is functional and policy-compliant. A broken link, a page missing contact information, or a page that makes claims the ad does not will all trigger disapproval. The fix is auditing your landing page before every ad submission.
The Regulatory Foundation Behind Meta's Policies
Meta's health-related advertising policies are built on federal regulatory frameworks. The restricted substances policy draws from FDA 503A and 503B, which define what constitutes legal compounding and what crosses into unapproved drug manufacturing. The healthcare policy reflects DSHEA 1994 standards around supplement claims and disease treatment prohibitions.
Understanding this regulatory foundation helps you predict what Meta will flag. Any claim that would violate FDA regulations will also violate Meta policy, even if the specific policy language does not mention the regulation by name. This is why we build every ad from the regulatory framework up, not from the policy document down.
The BAV verification process is the bridge between regulation and policy. Once your business is BAV-verified, Meta treats your ads with a different risk profile. Verified businesses get faster manual reviews and fewer automated rejections. We complete BAV verification as step one for every client, before a single ad is drafted.
The Four Fixes That Clear Most Disapprovals
Rewrite the ad as an educational resource. Replace every claim about what the peptide does with information about how compounding works. Instead of 'Our tirzepatide helps you lose weight,' write 'Compounded GLP-1 medications are available through licensed pharmacy consultations.' The same service, framed as education instead of promotion.
Audit your landing page against Meta's healthcare standards. Every landing page needs a clear FDA 503A or 503B disclaimer, a link to your pharmacy license, contact information including a physical address, a privacy policy, and terms of service. Missing any one of these is grounds for disapproval.
Replace clinical imagery with neutral visuals. No stethoscopes, no white coats, no syringe imagery, no before-and-after photos. Use images of your clinic interior, your compounding facility, or educational diagrams that explain how compounding works.
Submit supporting documentation with every appeal. When you request a manual review, attach your pharmacy license, your compounding permit, and a written summary of how the ad complies with FDA 503A or 503B. Reviewers are more likely to approve when the compliance documentation is in front of them during the review.
A Disapproval We Fixed in Under 48 Hours
A peptide clinic had 8 ads disapproved simultaneously for promoting prescription drug content. The ads all mentioned semaglutide by name and included language about weight loss outcomes. The landing page had no regulatory disclaimers and still referenced Ozempic as a comparison point.
We rewrote all 8 ads to focus on compounding consultation services, removing every drug name and weight loss claim. We rebuilt the landing page with FDA 503A compliance language, pharmacy license information, and a clear statement that compounded medications require a valid prescription. We submitted BAV verification documents alongside the appeal.
All 8 ads were approved within 48 hours. The client has not had a single peptide ad disapproved since, because the underlying compliance issues were resolved, not patched.
Related articles
Peptide Ads Rejected on Meta
Compounding Pharmacy Ads Banned
Ready to run these ads? Book a call → calendly.com/custodio-2/30min